Radiation therapy for breast cancer not responding to chemo
Part of Cancer, Skin clinical trials.
This trial tests whether adding a special type of radiation (SBRT) can help people whose breast cancer did not shrink after two rounds of standard chemotherapy. It's for people with stage II or III breast cancer that is still growing or stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with invasive breast cancer (stage II or III).
- Your cancer did not shrink after two cycles of standard chemotherapy (it stayed the same or got bigger).
- You have not had other cancers that needed treatment in the last 3 years.
- You are not currently taking high-dose steroids or other drugs that weaken the immune system.
- You are not pregnant or breastfeeding.
- Your blood counts and liver/kidney function are within safe limits (your doctor will check).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining two treatments—an immunotherapy drug (Toripalimab) and radiation—before surgery for a certain type of breast cancer (HR+, HER2-negative) that has spread to lymph nodes. The goal is to see if this combination helps shrink the tumor more than standard therapy alone.
This trial tests whether definitive radiation therapy can effectively treat breast cancer that cannot be surgically removed. It may be an option for people whose cancer is inoperable or who choose not to have surgery.
This trial tests whether combining the immunotherapy drug toripalimab with targeted radiation can help patients with HER2-negative breast cancer whose tumors did not shrink after initial chemotherapy. It aims to find a new treatment option for these patients.
This trial tests a precise type of radiation called SBRT for breast cancer in patients aged 70 or older who cannot have surgery or choose not to. The goal is to see if this treatment can effectively control the tumor without surgery.
This trial tests whether giving radiation to a few growing spots (1-3) can let you stay on your current drug longer, instead of switching to a new one right away. It's for people with metastatic breast cancer whose disease has been stable for months but now shows limited progression.
This trial tests a new approach for breast cancer that combines a short course of focused radiation (SBRT) with an injection of the immunotherapy drug pembrolizumab directly into the tumor, followed by standard chemotherapy before surgery. The goal is to see if this combination helps shrink the tumor more effectively before surgery.
Hear when a new Breast Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.